EUVIMEDEUVIMED entdecken
Crossref

Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative‐Intent Local Treatment for Recurrent Hepatocellular Carcinoma

Katsunori Sakamoto iD, Tomoaki Yoh, Satoshi Nomura iD, Kentaro Kadono, Hidenobu Kojima, Asahi Sato, Shoichi Kageyama, Hirofumi Hirao iD, Takahiro Nishio iD, Shinya Okumura iD, Daisuke Ueda, Masayuki Okuno iD und 10 weitere

Hepatology Research · 2026-11 · 56 (11) · 1632-1642

DOI: 10.1111/hepr.70235 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hepatology Research, online erschienen am 01.07.2026. Verfasst von Katsunori Sakamoto und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to investigate the prognostic impact of the interval between curative‐intent local treatments in patients undergoing repeated therapies for recurrent hepatocellular carcinoma after hepatectomy.

Methods

The present retrospective cohort study included 890 patients who underwent hepatectomy for HCC at our hospital between 2001 and 2020. Overall survival (OS) was evaluated from the time of each curative‐intent local treatment, according to the number of treatments received and the intervals between consecutive curative‐intent treatments for intrahepatic recurrence, up to the fourth session.

Results

During follow‐up, 625 patients (65.9%) developed intrahepatic recurrence. The median intervals gradually shortened to 24.9, 14.5, 12.4, and 12.8 months from hepatectomy to the first curative treatment, from the first to the second, from the second to the third, and from the third to the fourth treatments, respectively. For the first and second curative treatments, the pretreatment interval was not an independent predictor of OS. At the third curative treatment, an interval < 18.6 months between the second and third curative treatments independently predicted poorer OS (hazard ratio [HR] 2.280 and 95% confidence interval [CI] 1.046–4.967). For the fourth curative treatment, an interval < 14.1 months between the third and fourth treatments was an independent adverse prognostic factor (HR 4.961, 95% CI 1.607–15.319). The prognostic impact of treatment interval was more pronounced in patients who underwent ≥ 3 treatments, with a significant interaction compared with < 3 treatments.

Conclusions

Among patients who remained eligible for repeated curative‐intent local treatment, a shortened interval between treatments in late‐phase recurrence was an independent predictor of poor prognosis.

Schlagwörter

Stichwörter der Autor:innen

ablationhepatectomyhepatocellular carcinomalocal treatmentrecurrence

Autor:innen und Institutionen

  • Department of Surgery, Division of Hepato-Biliary-Pancreatic and Transplant Surgery, Graduate School of Medicine, Kyoto University, Kyoto, Japan.

ORCID-Profile: Katsunori Sakamoto, Satoshi Nomura, Hirofumi Hirao, Takahiro Nishio, Shinya Okumura, Masayuki Okuno, Takashi Ito, Takamichi Ishii, Etsuro Hatano

Zitieren

APA

Sakamoto, K., Yoh, T., Nomura, S., Kadono, K., Kojima, H., Sato, A., Kageyama, S., Hirao, H., Nishio, T., Okumura, S., Ueda, D., Okuno, M., Nishino, H., Yamane, K., Hirata, M., Ogiso, S., Okamoto, T., Nagai, K., Uchida, Y., …, & Hatano, E. (2026). Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative‐Intent Local Treatment for Recurrent Hepatocellular Carcinoma. Hepatology Research, 56(11), 1632-1642. https://doi.org/10.1111/hepr.70235

Vancouver

Sakamoto K, Yoh T, Nomura S, Kadono K, Kojima H, Sato A, et al. Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative‐Intent Local Treatment for Recurrent Hepatocellular Carcinoma. Hepatology Research. 2026;56(11):1632-1642. doi:10.1111/hepr.70235

BibTeX
@article{Sakamoto2026,
  author = {Sakamoto, Katsunori and Yoh, Tomoaki and Nomura, Satoshi and Kadono, Kentaro and Kojima, Hidenobu and Sato, Asahi and Kageyama, Shoichi and Hirao, Hirofumi and Nishio, Takahiro and Okumura, Shinya and Ueda, Daisuke and Okuno, Masayuki and Nishino, Hiroto and Yamane, Kei and Hirata, Masaaki and Ogiso, Satoshi and Okamoto, Tatsuya and Nagai, Kazuyuki and Uchida, Yoichiro and Ito, Takashi and Ishii, Takamichi and Hatano, Etsuro},
  title = {Treatment Interval as a Prognostic Marker in Patients Undergoing Repeated Curative‐Intent Local Treatment for Recurrent Hepatocellular Carcinoma},
  journal = {Hepatology Research},
  year = {2026},
  volume = {56},
  number = {11},
  pages = {1632--1642},
  doi = {10.1111/hepr.70235}
}
Kostenlos starten →